Melford A Larson Md is categorized under Internal Medicine Doctors in Manteca, CA and active since 1963.
Melford A Larson Md was established in 1963, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Melford A Larson at the company’s single location by writing to 520 East Center St, Manteca, California CA 95336 or by phoning (209) 823-2131. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Melford A Larson Md |
| Contact Person: | Melford A Larson |
| Address: | 520 East Center St, Manteca, California 95336 |
| Phone Number: | (209) 823-2131 |
| Website Address: | oxygentherapytoday.com |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 1963 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Internal Medicine Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Melford A Larson Md was started in 1963 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Melford A Larson for inquiries that concern Melford A Larson Md by calling the company number (209) 823-2131, as your correspondence is most welcome. Additionally, the physical location of the single location of Melford A Larson Md can be found at the coordinates 37.798953,-121.210413 as well as the street address 520 East Center St in Manteca, California 95336.
For its online presence, you may visit Melford A Larson Md’s website at oxygentherapytoday.com and engage with its social media outlets through on Twitter and on Facebook.